Clinical Trial Update: A Study Evaluating the Safety, Tolerability, and Efficacy of Aramchol Meglumine in Primary Sclerosing Cholangitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating Aramchol Meglumine for Primary Sclerosing Cholangitis has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sclerosing Cholangitis

Drugs mentioned

• Aramchol Meglumine

Snippet

Sponsor: Galmed Pharmaceuticals Ltd | Conditions: Primary Sclerosing Cholangitis | Phase 2 | Status: WITHDRAWN